By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company PetMed Express, Inc.

PetMed Express, Inc. (PETS)

NASDAQ Currency in USD
$456.00
+$7.67
+1.71%
Last Update: 18 Jul 2026, 14:21
$9.54bn
Market Cap
-165.82
P/E Ratio (TTM)
Forward Dividend Yield
$309.25-$554.38
52 Week Range

PETS Stock Price Chart

Explore PetMed Express, Inc. interactive price chart. Choose custom timeframes to analyze PETS price movements and trends.

PETS Company Profile

Discover essential business fundamentals and corporate details for PetMed Express, Inc. (PETS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

26 Apr 1999

Employees

287.00

CEO

Leslie C. G. Campbell

Description

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

PETS Financial Timeline

Browse a chronological timeline of PetMed Express, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 Dec 2026

EPS estimate is $0.12, while revenue estimate is $55.00m.

Upcoming earnings on 13 Oct 2026

EPS estimate is -$0.18, while revenue estimate is $62.00m.

Upcoming earnings on 6 Aug 2026

EPS estimate is $0.12, while revenue estimate is $71.00m.

Earnings released on 2 Jun 2026

EPS came in at -$0.19 falling short of the estimated -$0.18 by -5.56%, while revenue for the quarter reached $42.82m , missing expectations by -17.66%.

Earnings released on 5 Feb 2026

EPS came in at -$0.50 falling short of the estimated -$0.06 by -733.33%, while revenue for the quarter reached $40.66m , missing expectations by -24.77%.

Earnings released on 19 Dec 2025

EPS came in at -$0.34 falling short of the estimated -$0.02 by -1.60k%, while revenue for the quarter reached $44.36m , missing expectations by -35.99%.

Earnings released on 10 Feb 2025

EPS came in at -$0.03 falling short of the estimated $0.01 by -700.00%, while revenue for the quarter reached $52.98m , missing expectations by -1.88%.

Earnings released on 6 Nov 2024

EPS came in at $0.11 surpassing the estimated -$0.05 by +320.00%, while revenue for the quarter reached $59.57m , missing expectations by -9.74%.

Earnings released on 6 Aug 2024

EPS came in at $0.18 surpassing the estimated -$0.09 by +300.00%, while revenue for the quarter reached $67.95m , missing expectations by -9.40%.

Earnings released on 15 Apr 2024

EPS came in at -$0.10 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $66.50m , beating expectations by +2.31%.

Earnings released on 8 Feb 2024

EPS came in at -$0.10 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $65.32m , beating expectations by +0.49%.

Earnings released on 30 Oct 2023

EPS came in at -$0.00 falling short of the estimated $0.09 by -103.81%, while revenue for the quarter reached $71.00m , missing expectations by -6.58%.

Dividend declared on 11 Aug 2023

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 18 Aug 2023.

Earnings released on 31 Jul 2023

EPS came in at -$0.04 falling short of the estimated $0.07 by -157.14%, while revenue for the quarter reached $78.24m , missing expectations by -1.51%.

Dividend declared on 5 Jun 2023

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 12 Jun 2023.

Earnings released on 22 May 2023

EPS came in at -$0.25 falling short of the estimated $0.15 by -266.67%, while revenue for the quarter reached $62.41m , missing expectations by -5.08%.

Dividend declared on 16 Feb 2023

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 27 Feb 2023.

Earnings released on 6 Feb 2023

EPS came in at $0.02 falling short of the estimated $0.20 by -90.00%, while revenue for the quarter reached $58.87m , missing expectations by -5.10%.

Dividend declared on 17 Nov 2022

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 30 Nov 2022.

Earnings released on 7 Nov 2022

EPS came in at $0.13 falling short of the estimated $0.27 by -51.85%, while revenue for the quarter reached $65.39m , missing expectations by -0.01%.

Dividend declared on 11 Aug 2022

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 19 Aug 2022.

Earnings released on 25 Jul 2022

EPS came in at $0.14 falling short of the estimated $0.26 by -46.15%, while revenue for the quarter reached $70.19m , missing expectations by -10.31%.

Dividend declared on 19 May 2022

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 27 May 2022.

Earnings released on 9 May 2022

EPS came in at $0.30 surpassing the estimated $0.27 by +11.11%, while revenue for the quarter reached $66.00m , missing expectations by -3.30%.

Dividend declared on 4 Feb 2022

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 18 Feb 2022.

Earnings released on 24 Jan 2022

EPS came in at $0.21 falling short of the estimated $0.30 by -30.00%, while revenue for the quarter reached $60.72m , missing expectations by -5.30%.

Dividend declared on 5 Nov 2021

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 19 Nov 2021.

Earnings released on 25 Oct 2021

EPS came in at $0.31 falling short of the estimated $0.34 by -8.82%, while revenue for the quarter reached $67.39m , missing expectations by -11.01%.

Dividend declared on 5 Aug 2021

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 13 Aug 2021.

Earnings released on 26 Jul 2021

EPS came in at $0.26 falling short of the estimated $0.35 by -25.71%, while revenue for the quarter reached $79.31m , beating expectations by +4.76%.

PETS Stock Performance

Access detailed PETS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run